相关实验视频

Updated: Aug 7, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

血造干细胞基因编辑的p53挑战

Sofie R Dorset¹, Rasmus O Bak¹

¹Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

Molecular therapy. Methods & clinical development

|July 12, 2023

概括

活体基因编辑为血液疾病提供了有希望的治疗方法,通过精确地纠正血液造血干细胞中的DNA. 然而,DNA损伤反应可能会阻碍临床转化,需要进一步研究以获得安全有效的治疗方法.

科学领域:

血液学血液学血液学
基因治疗基因治疗
分子生物学分子生物学

背景情况:

血液造血干细胞和原生细胞 (HSPCs) 的ex vivo基因编辑是单一性血液疾病的潜在治疗方法.
同性导向修复 (HDR) 允许在HSPCs中进行精确的基因修改.

研究的目的:

研究基于HDR的基因编辑对单一性血液疾病的临床翻译方面的挑战.
了解HSPCs中HDR基因编辑诱导的DNA损伤反应 (DDR) 和p53激活.

主要方法:

在HSPC中使用基于HDR的基因编辑技术.
分析诱导DNA双链断裂和p53激活的情况.
评估DDR对HSPC扩散,植入和克隆能力的影响.

主要成果:

在HSPC中编辑HDR基因可以触发DNA损伤反应 (DDR) 和p53激活.
这种反应降低了编辑的HSPC的增殖,移植和克隆性能力.
缓解策略存在,但需要进一步调查.

结论:

虽然HDR基因编辑对单一性血液疾病具有前景,但DDR对临床应用构成重大障碍.
进一步的研究至关重要,以制定减轻DDR的策略,并确保在临床环境中基于HDR的基因编辑的安全性和效率.

关键词:

这就是CRISPR-Cas.这就是Cas9的情况.在DDR中,DDR是指DDR.对DNA损伤的反应反应 GSE56是什么意思?GSE56是什么意思?这就是HDR HDR.人力资源部的人力资源部这就是NHEJJ.这就是TALENs的意义.在ZFNs中使用ZFNs.基因编辑基因编辑同类的重组组合.同质性导向的维修是指导维修.p2121 在这个问题上.在p53中,p53是什么?sgRNARNA 是一个

更多相关视频

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

相关概念视频

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...